Physician profile
Simranjit Gulati
NPI 1578198289
$401.98
in general payments reported to CMS, 2019-2025
8 companies · $62.50 in 2025
The $62.50 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.14 · 2022: $79.71 · 2023: $49.90 · 2024: $159 · 2025: $62.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $111.13 | 2024-2025 | Repatha, Otezla, Repatha |
| Cranial Technologies, INC | $92.45 | 2021-2025 | Doc Band |
| Novo Nordisk INC | $70.42 | 2021-2023 | Wegovy |
| Glaxosmithkline, LLC. | $32.16 | 2021-2024 | Bexsero, Rotarix |
| Novartis Pharmaceuticals Corporation | $29.73 | 2025 | |
| Exact Sciences Corporation | $27.45 | 2024 | Cologuard Collection Kit |
| Alk-Abello, INC | $21.49 | 2024 | Ragwitek, Odactra, Grastek |
| Sanofi Pasteur INC. | $17.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simranjit Gulati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.